Judge Temporarily Blocks NIH Grant Indirect Cost Cut, Universities File Separate Challenge
A coalition of universities has launched a lawsuit in the District of Massachusetts against the NIH and the Department of Health and Human Services, joining one filed Monday by state attorneys general.

Conservative supporters of government deregulation want to do away with state-imposed licensing requirements, a move genetic counselors say will harm patients.
Oxford Team Debuts Multi-Modal MCED Approach Built on Exact Sciences Methylation Sequencing Tech
Premium
The group's TriOx assay sensitively detected cancers, including at early stages, using combined sequencing of methylation and gene alterations.
Grail Stock Surges on Quest Diagnostics Integration of Galleri MCED Test
Physicians can now order the blood-based multi-cancer early detection test through Quest as they might any of the lab firm's extensive menu of other blood tests.
The firm said that it does not expect NIH spending cuts, but its internal modeling shows the potential loss of 2025 revenues topping out at around $15 million.
Stellaromics Raises $80M in Series B Funding
The spatial biology company also unveiled its Pyxa platform, which is available for order now and will be shipped around the end of this year.
Craig-Hallum Initiates Coverage of Myriad Genetics With a Buy Rating
Craig-Hallum expects stable Prolaris revenues and sees opportunities for significant growth in the hereditary cancer and prenatal testing markets.